Related Experiment Videos
Arachidonic acid metabolism in glutathione-deficient macrophages
Abstract:
Mouse resident peritoneal macrophages were treated with the glutathione (GSH) synthesis inhibitor buthionine sulfoximine to deplete intracellular GSH. The arachidonic acid metabolites released by the GSH-depleted macrophages in response to a zymosan challenge were analyzed by HPLC. Buthionine sulfoximine treatment resulted in inhibition of both prostaglandin E2 and leukotriene C synthesis that was directly related to the degree of GSH depletion. Macrophages in which GSH levels were reduced to 3% of normal exhibited reductions to 4% and 1%, respectively, in PGE2 and LTC formation. The total quantity of cyclooxygenase metabolites secreted by GSH-deficient macrophages was identical to that of control cells as a result of increased synthesis of prostacyclin and, to a lesser extent, 12-L-hydroxy-5,8,10-heptadecatrienoic acid. Total lipoxygenase products were decreased, however; increased formation of hydroxyicosatetraenoic acids only partially compensated for the deficit in leukotriene C production. These findings extent our earlier observations on the inhibition of leukotriene C synthesis in GSH-depleted macrophages and confirm with intact cells the previously suggested role of GSH in prostaglandin E2 formation.
Insights
Glutathione depletion in macrophages significantly inhibits prostaglandin E2 and leukotriene C synthesis. This study reveals glutathione's crucial role in inflammatory mediator production by immune cells.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Glutathione (GSH) is a critical intracellular antioxidant.
- Macrophages play a key role in inflammatory responses.
- Arachidonic acid metabolites are important signaling molecules in inflammation.
Purpose of the Study:
- To investigate the role of intracellular glutathione (GSH) in the synthesis of arachidonic acid metabolites by macrophages.
- To determine the impact of GSH depletion on prostaglandin E2 (PGE2) and leukotriene C (LTC) production in macrophages stimulated with zymosan.
Main Methods:
- Primary mouse peritoneal macrophages were treated with buthionine sulfoximine, a GSH synthesis inhibitor, to deplete intracellular GSH.
- Zymosan was used to challenge the GSH-depleted macrophages.
- High-performance liquid chromatography (HPLC) was employed to analyze the arachidonic acid metabolites released by the macrophages.
Main Results:
- Buthionine sulfoximine treatment inhibited both PGE2 and LTC synthesis in a dose-dependent manner, directly correlating with the degree of GSH depletion.
- Macrophages with GSH levels reduced to 3% of normal showed significant reductions in PGE2 (to 4%) and LTC (to 1%) formation.
- While total lipoxygenase products decreased, increased synthesis of prostacyclin and 12-hydroxyheptadecatrienoic acid compensated for the reduced PGE2, maintaining total cyclooxygenase metabolite levels.
Conclusions:
- Intracellular glutathione (GSH) is essential for the synthesis of prostaglandin E2 and leukotriene C by macrophages.
- GSH depletion significantly impairs the production of key inflammatory mediators.
- These findings confirm the role of GSH in both PGE2 and LTC formation in intact macrophage cells.